Pfizer In Talks To Merge Its Off-Patent Drugs Business With Mylan To Create Generic Drug Giant

The deal, if completed, could be announced as early as Monday. The deal would bring together two businesses whose sales have slowed since former big sellers lost patent protection and began facing lower-priced competition. In other pharmaceutical news: black box warnings, antibiotics, and biotech's burning questions.

from Kaiser Health News https://ift.tt/314jXK1